Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Einat Shacham‐Shmueli, Rasha Cosman et al.|Nature Medicine|2023Cited by 128
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh et al.|Nature Medicine|2025Cited by 104
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemiaStephen K. Tahir, Darren C. Phillips, Emiliano Calvo et al.|Blood|2023Cited by 30
Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with <i>KRAS G12C</i> mutationJayesh Desai, Manish Patel, Sae‐Won Han et al.|Cancer Research|2023Cited by 10